Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Oncology: Basic, Translational & Therapy: Basic Science

  • You have access
    Modification of chemical structure to improve biodistribution of a radiolabeled sigma ligand for tumor-imaging
    Hiroya Kanbara, Kazuma Ogawa, Kazuhiro Shiba, Yoji Kitamura, Tatsuto Kiwada and Akira Odani
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1725;
  • You have access
    A Cy5** labelled anti-EGFR affibody selectively targets EGFR in mouse xenograft model
    Roger Bjerke, Anne-Marie Hvoslef, Bente Arbo, Stein Waagene, Gerd Torgersen, Astri Rogstad, Grete Kindberg and Edvin Johannesen
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1724;
  • You have access
    Radioimmunodetection of neuroblastoma: Expression of target antigen GD2 is changed by retinoic acid
    Jason Dearling, Stephan Voss, S. Ted Treves and Alan Packard
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1675;
  • You have access
    Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter
    Zhen Zhao
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1685;
  • You have access
    Intratumor non-uniform and mismatch-pattern distribution of 18F-FLT and 18F-FDG activity in human non-small cell lung cancer in mice by micro PET and histological correlates
    Xiao-Feng Li, Tao Huang, Junling Li, Huaiyu Zheng, A. Civelek, Gregory Postel and Chin Ng
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1695;
  • You have access
    Investigating optimal methods for assessing early response of head and neck cancer xenografts (HNCX) to hypofractionated radiation therapy (RT) using F-18 FDG-microPET-CT (PET)
    Ching-yee Wong, Jiayi Huang, Mitual Amin, John Chunta, David Lee, Inga Grills, Brian Marples, Di Yan, Alvaro Martinez and George Wilson
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1722;
  • You have access
    Functional analysis of adenoviral induced HSV-TK expression using a breast cancer-specific vs. a non-specific promoter
    Melinda Wuest, Alan DeSilva, Monica Wang, Hans-Soenke Jans, Frank Wuest and Mary Hitt
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1721;
  • You have access
    18F-FDG MicroPET imaging to evaluate molecularly-targeted agent efficacy in genetically-engineered rhabdomyosarcoma models
    Anu Soundararajan, Laura Nelon, Lee Ann Zarzabal, Joel Michalek and Charles Keller
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1696;
  • You have access
    18F-FDG PET/CT imaging of pancreatic tumor xenografts to evaluate a novel anti-EMMPRIN mAb
    Nemil Shah, Guihua Zhai, Joseph Knowles, Cecil Stockard, William Grizzle, Naomi Fineberg, Tong Zhou, Kurt Zinn, Eben Rosenthal and Hyunki Kim
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1720;
  • You have access
    The effect of radiation exposure on multidrug resistance in non-small lung cancer cells
    Shohei Kanno, Keita Utsunomiya, Koshi Ikeda, Atsushi Komemushi, Yoko Harima, Yasuhiro Ueno, Sangikil-HA Kawa and Satoshi Sawada
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1713;

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 10
SNMMI

© 2025 SNMMI

Powered by HighWire